A rationally designed peptide enhances homologous recombination in vitro and resistance to DNA damaging agents in vivo

被引:0
|
作者
Chen, Li-Tzu [1 ,2 ]
Wang, Andrew H. -J. [1 ,2 ]
机构
[1] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan
[2] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan
关键词
ESCHERICHIA-COLI RECA; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURES; HELICAL FILAMENTS; COMPLEX-FORMATION; RAD51; PROTEIN; DMC1; REPAIR; STABILIZATION;
D O I
10.1093/nar/gkq182
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RecA family of proteins is essential in homologous recombination, a critical step in DNA repair. Here, we report that a rationally-designed small peptide based on the crystal structure of Escherichia coli RecA-DNA complex can promote homologous recombination through the enhancement of both RecA-mediated strand assimilation and three-strand exchange activity. Among 17 peptides tested, peptide #3 with the amino acid sequence of IRFLTARRR has the most potent activity in promoting the RecA-mediated D-loop formation by similar to 7.2-fold at 37 degrees C. Other peptides such as IRFLTAKKK and IRLLTARRR also have similar, albeit lower, activities. Therefore, hydrophobicity and poly-positive charges, and the space between them in those small peptides are crucial features for such activities. The enhancement of recombination by these peptides appears to be a general phenomenon as similar results were seen by using different plasmids. Remarkably, peptide #3 alone without RecA can also promote the D-loop formation at elevated temperature. Cell viability assays showed that the peptide elevates mammalian cell resistance to two cytotoxic DNA drugs, cisplatin and doxorubicin. The rescue of viability may result from increased DNA repair efficiency. Such peptides may find future biological applications.
引用
收藏
页码:4361 / 4371
页数:11
相关论文
共 50 条
  • [1] Induction of homologous recombination following in utero exposure to DNA-damaging agents
    Karia, Bijal
    Martinez, Jo Ann
    Bishop, Alexander J. R.
    DNA REPAIR, 2013, 12 (11) : 912 - 921
  • [2] Pharmacological inhibition of ubiquitination sensitizes to DNA damaging agents by preventing homologous recombination repair
    Awasthi, Sharad
    Yi, S. Stephen
    McGrail, Daniel J.
    Sahni, Nidhi
    CANCER RESEARCH, 2023, 83 (08)
  • [3] Modulating Self-Assembly of DNA Crystals with Rationally Designed Agents
    Zhao, Jiemin
    Zhao, Yue
    Li, Zhe
    Wang, Yong
    Sha, Ruojie
    Seeman, Nadrian C.
    Mao, Chengde
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (50) : 16529 - 16532
  • [4] Interplay of DNA repair, homologous recombination, and DNA polymerases in resistance to the DNA damaging agent 4-nitroquinoline-1-oxide in Escherichia coli
    Williams, Ashley B.
    Hetrick, Kyle M.
    Foster, Patricia L.
    DNA REPAIR, 2010, 9 (10) : 1090 - 1097
  • [5] Rationally Designed DNA-Origami Nanomaterials for Drug Delivery In Vivo
    Jiang, Qiao
    Liu, Shaoli
    Liu, Jianbing
    Wang, Zhen-Gang
    Ding, Baoquan
    ADVANCED MATERIALS, 2019, 31 (45)
  • [6] Direct ex vivo observation of homologous recombination defect reversal after DNA damaging chemotherapy in metastatic breast cancer patients
    Meijer, T. G.
    Verkaik, N. S.
    Van Deurzen, C. H.
    Dubbink, H. J.
    Den, T. D.
    Dinjens, W. N.
    Kanaar, R.
    Van Gent, D. C.
    Jager, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [7] Homologous recombination deficiency in the CCLE cell lines correlates with in vitro resistance to platinum agents and PARP inhibitors
    Takamatsu, Shiro
    Matsumura, Noriomi
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Administration of rosemary essential oil enhances resistance of rat hepatocytes against DNA-damaging oxidative agents
    Horvathova, Eva
    Slamenova, Darina
    Navarova, Jana
    FOOD CHEMISTRY, 2010, 123 (01) : 151 - 156
  • [9] Direct Ex Vivo Observation of Homologous Recombination Defect Reversal After DNA-Damaging Chemotherapy in Patients With Metastatic Breast Cancer
    Meijer, Titia G.
    Verkaik, Nicole S.
    van Deurzen, Carolien H. M.
    Dubbink, Hendrikus-Jan
    den Toom, T. Dorine
    Sleddens, Hein F. B. M.
    De Hoop, Esther Oomen
    Dinjens, Winand N. M.
    Kanaar, Roland
    van Gent, Dik C.
    Jager, Agnes
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 12
  • [10] Targeting BARD1 slows PDAC growth in vitro and in vivo and sensitizes cells to DNA damaging agents
    Patel, Sohum
    Arkala, Anoohya
    Nevler, Avinoam
    Coats, Carolyn
    Yeo, Charles J.
    Jain, Aditi
    CANCER RESEARCH, 2023, 83 (07)